Endra Life Sciences (Nasdaq: Ndra)

Endra, Inc. provides photoacoustic products and medical imaging technologies in the United States. It offers Nexus 128, a preclinical photoacoustic computed tomography scanner for small animal imaging, as well as is used for non-invasive quantification of tumor vasculature and other physiological parameters for preclinical research. The company’s products provide rapid functional images of structures, such as tumors, blood vessels, lymph nodes, and other tissues. Endra, Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.